Nepal grants conditional emergency use approval to Russian Sputnik V vaccine

This is the fourth Covid-19 vaccine to get emergency use approval after AstraZeneca’s Covishield, Bharat Biotech’s Covaxin and Sinopharm’s BBIBP-CorV.

At a time when the country is witnessing a steep surge in new cases, Nepal’s national drug regulatory authority has granted